In Malaysia, cervical cancer is the top 3 most common cancer among women.
Cervical cancer strikes women
in the prime of their lives - 3 out of 4 women in Malaysia with
cervical cancer are below the age of 64.
99% of cervical cancer
cases are caused by high-risk HPV (Human Papillomavirus) types.
Only 25% of eligible women had a pap smear done
from 2013 to 2017.
Barriers to a successful
screening program related to the conventional screening method, Pap smear are:
ROSE uses a revolutionary approach to cervical screening by:
Pilot Project ROSE is a research program led by University of Malaya that aims to assess acceptability,
feasibility and reach of a novel cervical screening strategy that utilizes
self-collected,HPV testing in primary care settings and
follow-up of screened positive women in tertiary hospital in Malaysia.
The overall program encompasses a series of pilot projects that is designed to screen more women and systematically evaluate the outcomes in the different community settings (e.g. urban poor and rural) within the Malaysian setting. The results generated will inform the stakeholders on strategies to increase uptake of cervical screening in the most cost effective, acceptable and feasible manner in the Malaysian context.
This fundraising drive will enable a pilot project that will screen 2000 women to be executed using the ROSE intervention.
'Our vision is a cervical cancer free future for Malaysian women'